NPI: 1407877137 · STATEN ISLAND, NY 10305 · General Acute Care Hospital · NPI assigned 07/21/2006
Authorized official CUSACK, MICHELE controls 20+ related entities in our dataset. Read more
| Authorized Official | CUSACK, MICHELE (SENIOR VICE PRESIDENT AND CFO) |
| NPI Enumeration Date | 07/21/2006 |
Other providers sharing the same authorized official: CUSACK, MICHELE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,237 | $1.07M |
| 2019 | 195,760 | $8.53M |
| 2020 | 323,792 | $16.84M |
| 2021 | 393,211 | $21.82M |
| 2022 | 424,059 | $23.20M |
| 2023 | 448,054 | $25.63M |
| 2024 | 365,609 | $21.03M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 503,162 | 43,583 | $18.92M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 59,552 | 56,111 | $10.45M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 81,424 | 63,120 | $10.10M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 47,311 | 44,586 | $7.83M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 24,096 | 21,361 | $4.17M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 19,565 | 18,956 | $3.37M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30,667 | 27,673 | $3.37M |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 28,363 | 19,562 | $3.22M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 13,277 | 12,980 | $3.03M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23,193 | 19,792 | $2.58M |
| G0378 | Hospital observation service, per hour | 4,581 | 3,831 | $2.56M |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 911 | 904 | $1.77M |
| 70450 | Computed tomography, head or brain; without contrast material | 8,530 | 8,204 | $1.71M |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 17,383 | 15,776 | $1.59M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2,572 | 2,554 | $1.57M |
| C1889 | Implantable/insertable device, not otherwise classified | 2,104 | 2,073 | $1.45M |
| 90832 | Psychotherapy, 30 minutes with patient | 11,439 | 7,615 | $1.42M |
| 80053 | Comprehensive metabolic panel | 70,470 | 62,051 | $1.35M |
| 36415 | Collection of venous blood by venipuncture | 105,147 | 76,847 | $1.25M |
| G0397 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes | 7,611 | 6,115 | $1.17M |
| 93970 | 2,354 | 2,308 | $1.08M | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1,494 | 1,478 | $1.04M |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2,878 | 2,830 | $848K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 10,816 | 9,365 | $781K |
| 90834 | Psychotherapy, 45 minutes with patient | 4,726 | 3,118 | $778K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 16,772 | 4,381 | $758K |
| H0050 | Alcohol and/or drug services, brief intervention, per 15 minutes | 14,284 | 9,577 | $743K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 7,097 | 7,024 | $729K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 6,924 | 3,611 | $645K |
| 12001 | 1,358 | 1,353 | $558K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1,173 | 1,164 | $543K |
| 99215 | Prolong outpt/office vis | 4,351 | 4,038 | $458K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 536 | 520 | $452K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 4,615 | 4,263 | $442K |
| 12011 | 1,099 | 1,096 | $435K | |
| 36430 | 623 | 450 | $427K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,821 | 1,796 | $416K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,060 | 1,912 | $409K |
| D0120 | Periodic oral evaluation - established patient | 10,691 | 6,760 | $398K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 1,430 | 1,413 | $389K |
| 86850 | 11,075 | 10,340 | $382K | |
| 76770 | 1,748 | 1,723 | $370K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 746 | 488 | $355K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 3,394 | 2,044 | $349K |
| D7140 | Extraction, erupted tooth or exposed root | 6,044 | 4,561 | $343K |
| 29515 | 1,590 | 1,563 | $335K | |
| 76830 | Ultrasound, transvaginal | 4,707 | 4,538 | $320K |
| 76819 | Fetal biophysical profile; without non-stress testing | 3,782 | 2,283 | $291K |
| 75574 | 1,322 | 1,313 | $291K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 2,023 | 2,003 | $283K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,459 | 1,440 | $277K |
| 36416 | 14,659 | 4,868 | $274K | |
| 77066 | Tomosynthesis, mammo | 2,275 | 2,240 | $261K |
| 90837 | Psychotherapy, 53 minutes with patient | 1,775 | 1,095 | $261K |
| C1769 | Guide wire | 1,543 | 1,474 | $258K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2,085 | 2,049 | $251K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 664 | 657 | $249K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2,402 | 2,349 | $249K |
| G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 15,455 | 5,703 | $249K |
| 29125 | 1,134 | 1,120 | $242K | |
| 10060 | 820 | 802 | $241K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 13,239 | 11,979 | $241K |
| 86901 | 10,585 | 9,929 | $238K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 2,361 | 2,296 | $232K |
| 76641 | 3,096 | 2,804 | $226K | |
| D0140 | Limited oral evaluation - problem focused | 11,624 | 10,111 | $226K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 5,709 | 5,537 | $215K |
| 70496 | 1,065 | 1,052 | $213K | |
| 96415 | 526 | 384 | $210K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 3,682 | 3,621 | $207K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,242 | 1,231 | $204K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1,941 | 1,930 | $201K |
| 64400 | 487 | 472 | $199K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1,970 | 1,861 | $198K |
| 86900 | 11,241 | 10,496 | $198K | |
| 77065 | Tomosynthesis, mammo | 2,268 | 1,960 | $196K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 327 | 322 | $189K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 9,595 | 9,370 | $186K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 7,099 | 7,037 | $183K |
| D0220 | Intraoral - periapical first radiographic image | 11,402 | 10,066 | $180K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 697 | 693 | $178K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,014 | 888 | $176K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 13,380 | 12,221 | $173K |
| 95800 | 139 | 132 | $173K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1,746 | 1,629 | $168K |
| 90791 | Psychiatric diagnostic evaluation | 978 | 892 | $167K |
| D1120 | Prophylaxis - child | 4,443 | 4,441 | $167K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,424 | 1,407 | $165K |
| 76818 | 1,714 | 779 | $165K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,471 | 1,454 | $159K |
| 93308 | 565 | 560 | $154K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 23,800 | 22,261 | $151K |
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) | 2,480 | 1,001 | $151K |
| D0230 | Intraoral - periapical each additional radiographic image | 10,184 | 9,303 | $150K |
| 76642 | 2,848 | 2,513 | $146K | |
| J1756 | Injection, iron sucrose, 1 mg | 2,370 | 1,113 | $146K |
| J3490 | Unclassified drugs | 18,840 | 14,767 | $142K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 9,278 | 5,953 | $141K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 3,611 | 3,516 | $141K |
| 71250 | 1,326 | 1,305 | $138K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,861 | 1,695 | $131K |
| 11721 | 2,174 | 2,014 | $130K | |
| 10E0XZZ | 270 | 30 | $126K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 9,728 | 9,478 | $126K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3,728 | 3,362 | $125K |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 628 | 608 | $122K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1,104 | 1,090 | $121K |
| 83880 | 5,258 | 5,076 | $120K | |
| 76536 | 1,265 | 1,252 | $119K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1,010 | 1,007 | $116K |
| 71046 | Radiologic examination, chest; 2 views | 13,577 | 13,219 | $115K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 5,252 | 1,716 | $115K |
| 93458 | 53 | 52 | $114K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 3,116 | 3,062 | $114K |
| J7050 | Infusion, normal saline solution, 250 cc | 7,943 | 4,052 | $113K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 1,936 | 1,383 | $111K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1,072 | 1,070 | $111K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 2,371 | 1,568 | $109K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 3,971 | 1,268 | $107K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 831 | 821 | $106K |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 1,568 | 1,151 | $105K |
| 76813 | 1,117 | 1,101 | $105K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 101 | 94 | $103K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 28,909 | 26,379 | $102K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 901 | 778 | $99K |
| 80061 | Lipid panel | 8,110 | 8,000 | $96K |
| 92550 | 1,273 | 1,266 | $94K | |
| 59025 | Fetal non-stress test | 528 | 485 | $92K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 991 | 987 | $87K |
| D1110 | Prophylaxis - adult | 2,361 | 2,351 | $86K |
| D0150 | Comprehensive oral evaluation - new or established patient | 2,429 | 1,811 | $85K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 731 | 729 | $81K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4,341 | 4,170 | $79K |
| P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | 212 | 152 | $77K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 636 | 636 | $76K |
| D1208 | Topical application of fluoride, excluding varnish | 5,815 | 5,804 | $76K |
| 80076 | 7,665 | 7,269 | $76K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3,435 | 3,387 | $75K |
| 90715 | 3,236 | 3,221 | $74K | |
| 85610 | 24,179 | 17,919 | $74K | |
| 58558 | 57 | 56 | $74K | |
| H0034 | Medication training and support, per 15 minutes | 2,636 | 1,924 | $73K |
| 0225U | 6,085 | 5,971 | $72K | |
| 70486 | 1,037 | 1,018 | $71K | |
| 72197 | 175 | 173 | $70K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | 367 | 355 | $68K |
| 12002 | 176 | 176 | $67K | |
| A4648 | Tissue marker, implantable, any type, each | 394 | 377 | $66K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 558 | 556 | $65K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 242 | 206 | $65K |
| 76870 | 942 | 926 | $64K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 206 | 82 | $63K |
| 96367 | 1,097 | 709 | $61K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 49,311 | 43,691 | $61K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,665 | 2,593 | $61K |
| 99205 | Prolong outpt/office vis | 372 | 368 | $61K |
| C1781 | Mesh (implantable) | 134 | 134 | $61K |
| 96375 | Therapeutic injection; each additional sequential IV push | 12,561 | 11,695 | $60K |
| 82803 | 3,753 | 3,546 | $60K | |
| 85027 | 18,033 | 15,375 | $60K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 863 | 828 | $60K |
| D0330 | Panoramic radiographic image | 2,549 | 2,508 | $60K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2,004 | 1,992 | $59K |
| G9012 | Other specified case management service not elsewhere classified | 2,360 | 1,375 | $59K |
| D1351 | Sealant - per tooth | 2,034 | 1,012 | $58K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 334 | 331 | $57K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 12,636 | 12,128 | $57K |
| 88304 | 2,266 | 2,230 | $55K | |
| 86480 | 905 | 902 | $55K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 1,267 | 1,171 | $54K |
| 16020 | 147 | 131 | $52K | |
| C9399 | Unclassified drugs or biologicals | 807 | 804 | $49K |
| 83036 | Hemoglobin; glycosylated (A1C) | 8,759 | 8,620 | $48K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 634 | 288 | $48K |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 2,617 | 2,541 | $48K |
| A9505 | Thallium tl-201 thallous chloride, diagnostic, per millicurie | 501 | 499 | $48K |
| 77080 | 1,064 | 1,055 | $48K | |
| D0272 | Bitewings - two radiographic images | 4,405 | 4,403 | $47K |
| 92134 | 786 | 757 | $47K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 51 | 50 | $45K |
| J7030 | Infusion, normal saline solution , 1000 cc | 14,505 | 13,192 | $45K |
| 70491 | 217 | 215 | $44K | |
| 72141 | 184 | 182 | $43K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 776 | 740 | $43K |
| 90670 | 3,218 | 3,201 | $43K | |
| 84443 | Thyroid stimulating hormone (TSH) | 6,152 | 6,003 | $42K |
| 73630 | 3,288 | 3,072 | $42K | |
| 36000 | 1,465 | 1,433 | $40K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 4,416 | 4,317 | $39K |
| 72082 | 588 | 581 | $38K | |
| 83655 | 2,658 | 2,642 | $38K | |
| J1453 | Injection, fosaprepitant, 1 mg | 618 | 375 | $37K |
| D8670 | Periodic orthodontic treatment visit | 184 | 184 | $36K |
| 72110 | 832 | 831 | $35K | |
| 93017 | 374 | 373 | $35K | |
| 99051 | 2,937 | 2,883 | $35K | |
| 88312 | 2,179 | 2,150 | $35K | |
| 96139 | 333 | 274 | $34K | |
| A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | 233 | 214 | $34K |
| 74183 | 97 | 95 | $34K | |
| 96417 | 605 | 401 | $34K | |
| 95782 | 31 | 31 | $33K | |
| 97116 | 1,833 | 1,054 | $32K | |
| 90685 | 3,640 | 3,625 | $31K | |
| 73562 | 2,230 | 2,094 | $31K | |
| 77412 | 71 | 12 | $31K | |
| 92557 | 725 | 721 | $31K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 295 | 294 | $31K |
| H0014 | Alcohol and/or drug services; ambulatory detoxification | 163 | 130 | $29K |
| 76775 | 526 | 524 | $28K | |
| 71045 | Radiologic examination, chest; single view | 11,275 | 10,579 | $27K |
| 76801 | 269 | 266 | $27K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 2,073 | 1,840 | $27K |
| 88142 | 1,039 | 1,038 | $27K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 5,751 | 5,677 | $25K |
| 94070 | 532 | 531 | $25K | |
| 96138 | 316 | 261 | $25K | |
| 88307 | 347 | 342 | $25K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,632 | 1,582 | $25K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 84 | 84 | $25K |
| 97161 | 259 | 257 | $24K | |
| 87481 | 612 | 607 | $23K | |
| H0038 | Self-help/peer services, per 15 minutes | 572 | 368 | $23K |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 50 | 48 | $23K |
| 99381 | 186 | 185 | $23K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 302 | 302 | $22K |
| 70498 | 809 | 799 | $22K | |
| D2930 | Prefabricated stainless steel crown - primary tooth | 242 | 209 | $22K |
| 87653 | 1,219 | 1,204 | $22K | |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 131 | 126 | $22K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 3,497 | 3,419 | $21K |
| 82728 | 3,224 | 3,133 | $21K | |
| 94729 | 545 | 541 | $21K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 13,901 | 12,914 | $21K |
| 97010 | 3,199 | 1,004 | $21K | |
| 87641 | 735 | 734 | $21K | |
| 90648 | 2,273 | 2,265 | $21K | |
| 51701 | 64 | 64 | $20K | |
| 19083 | 27 | 27 | $20K | |
| 73130 | 2,423 | 2,314 | $20K | |
| 80050 | General health panel | 79 | 78 | $20K |
| HZ2ZZZZ | 82 | 12 | $20K | |
| 81025 | 3,846 | 3,717 | $20K | |
| 93971 | 206 | 202 | $19K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 13,348 | 11,527 | $19K |
| 85730 | 10,585 | 10,150 | $19K | |
| 90651 | 421 | 416 | $18K | |
| D9310 | 720 | 720 | $18K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 183 | 68 | $18K |
| 96116 | 95 | 92 | $17K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 14 | 14 | $17K |
| 82962 | 12,480 | 9,560 | $17K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 4,938 | 3,876 | $17K |
| 73030 | 1,866 | 1,759 | $17K | |
| 97162 | 167 | 164 | $17K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 13 | 13 | $17K |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | 243 | 213 | $16K |
| 90680 | 1,755 | 1,745 | $16K | |
| J2704 | Injection, propofol, 10 mg | 4,800 | 4,278 | $16K |
| 81507 | 57 | 57 | $16K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 12 | 12 | $16K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2,015 | 1,998 | $15K |
| 92133 | 244 | 244 | $15K | |
| 92060 | 216 | 207 | $15K | |
| 73610 | 2,265 | 2,170 | $14K | |
| 99242 | 132 | 132 | $14K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 13,820 | 13,246 | $14K |
| 90633 | 1,497 | 1,491 | $14K | |
| 94726 | 329 | 329 | $14K | |
| 73110 | 1,593 | 1,511 | $13K | |
| 82607 | 1,429 | 1,400 | $13K | |
| 86780 | 2,872 | 2,850 | $13K | |
| 88342 | 397 | 386 | $13K | |
| 97165 | 145 | 142 | $13K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 4,937 | 4,269 | $13K |
| 85380 | 594 | 588 | $12K | |
| 90723 | 1,634 | 1,629 | $12K | |
| 99442 | 78 | 75 | $12K | |
| 90686 | 675 | 655 | $12K | |
| 86703 | 1,026 | 1,016 | $12K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 3,770 | 3,687 | $12K |
| 99406 | 179 | 179 | $11K | |
| 76937 | 83 | 80 | $11K | |
| 84439 | 1,470 | 1,440 | $11K | |
| 81002 | 9,234 | 6,299 | $11K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2,149 | 2,083 | $11K |
| 97802 | 251 | 251 | $11K | |
| 97597 | 37 | 26 | $11K | |
| 59820 | 13 | 13 | $11K | |
| 80074 | 323 | 320 | $11K | |
| 86701 | 944 | 936 | $11K | |
| 81513 | 565 | 560 | $10K | |
| 76820 | 240 | 108 | $10K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 4,436 | 4,176 | $10K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 156 | 102 | $9K |
| J1170 | Injection, hydromorphone, up to 4 mg | 2,316 | 2,056 | $9K |
| 87631 | 262 | 259 | $9K | |
| 96376 | 2,198 | 2,113 | $9K | |
| 83020 | 1,234 | 1,208 | $9K | |
| D2150 | Silver amalgam - two surfaces, primary or permanent | 238 | 205 | $9K |
| 86803 | 1,620 | 1,608 | $9K | |
| 90716 | 635 | 633 | $9K | |
| 0042T | 137 | 137 | $9K | |
| 96132 | 191 | 153 | $8K | |
| 88341 | 211 | 204 | $8K | |
| 86762 | 925 | 916 | $8K | |
| 86003 | 97 | 57 | $8K | |
| 73080 | 1,012 | 949 | $8K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 70 | 67 | $8K |
| 83735 | 9,855 | 8,274 | $8K | |
| G0008 | Administration of influenza virus vaccine | 430 | 429 | $8K |
| 84702 | 3,099 | 2,773 | $8K | |
| 97602 | 13 | 13 | $8K | |
| 90698 | 877 | 872 | $7K | |
| 74018 | 960 | 900 | $7K | |
| 29130 | 37 | 37 | $7K | |
| 83605 | 10,648 | 9,959 | $7K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 5,786 | 4,851 | $7K |
| 77336 | 17 | 12 | $7K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 806 | 687 | $7K |
| 73502 | 490 | 473 | $7K | |
| 87536 | 69 | 69 | $7K | |
| 97803 | 171 | 167 | $7K | |
| J2785 | Injection, regadenoson, 0.1 mg | 27 | 26 | $7K |
| 81003 | 7,822 | 7,647 | $7K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,480 | 1,430 | $7K |
| 87340 | 1,833 | 1,818 | $7K | |
| 86923 | 228 | 180 | $6K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,297 | 1,056 | $6K |
| D9110 | 273 | 265 | $6K | |
| A0425 | Ground mileage, per statute mile | 686 | 612 | $6K |
| 83540 | 2,293 | 2,243 | $6K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 88 | 87 | $6K |
| 90734 | 435 | 435 | $6K | |
| 83520 | 101 | 97 | $6K | |
| 96121 | 94 | 91 | $6K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 44 | 44 | $6K |
| 90707 | 628 | 623 | $6K | |
| 86765 | 638 | 632 | $6K | |
| 82378 | 644 | 596 | $5K | |
| 84484 | 11,636 | 10,188 | $5K | |
| 81001 | 11,337 | 10,828 | $5K | |
| S2900 | Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) | 108 | 107 | $5K |
| 16025 | 22 | 16 | $5K | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 612 | 601 | $5K |
| 83550 | 2,249 | 2,201 | $5K | |
| 76857 | 488 | 462 | $5K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 676 | 647 | $5K |
| 73221 | 12 | 12 | $5K | |
| 82746 | 757 | 742 | $5K | |
| 92567 | 85 | 84 | $5K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 216 | 187 | $5K |
| 99459 | 489 | 476 | $5K | |
| 71271 | 69 | 69 | $5K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,891 | 1,778 | $5K |
| 83690 | 14,087 | 13,294 | $5K | |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | 60 | 58 | $5K |
| 72170 | 1,335 | 1,303 | $5K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 3,752 | 3,623 | $4K |
| 96402 | 110 | 103 | $4K | |
| 72100 | 206 | 206 | $4K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 3,359 | 3,245 | $4K |
| 73090 | 1,008 | 964 | $4K | |
| 87186 | 2,243 | 2,174 | $4K | |
| 92579 | 80 | 79 | $4K | |
| 96130 | 86 | 67 | $4K | |
| 80367 | 784 | 710 | $4K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 34 | 26 | $4K |
| D0274 | Bitewings - four radiographic images | 249 | 248 | $4K |
| 73590 | 1,144 | 1,101 | $4K | |
| 90700 | 490 | 484 | $4K | |
| 77072 | 119 | 119 | $4K | |
| 92551 | 66 | 66 | $4K | |
| 81329 | 228 | 228 | $4K | |
| 86787 | 671 | 664 | $4K | |
| 58300 | 26 | 26 | $4K | |
| 74178 | 16 | 15 | $4K | |
| 84153 | 160 | 160 | $4K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,633 | 1,567 | $3K |
| 76882 | 145 | 123 | $3K | |
| 94664 | 287 | 286 | $3K | |
| 90677 | 14 | 14 | $3K | |
| 83615 | 1,549 | 1,462 | $3K | |
| 74174 | 31 | 29 | $3K | |
| 83970 | 56 | 56 | $3K | |
| 72050 | 52 | 51 | $3K | |
| 86769 | 563 | 550 | $3K | |
| 86706 | 358 | 353 | $3K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,931 | 2,186 | $3K |
| 86355 | 79 | 78 | $3K | |
| 94727 | 122 | 122 | $3K | |
| 87522 | Neg quan hep c or qual rna | 68 | 67 | $3K |
| 84403 | 70 | 66 | $2K | |
| 92002 | 14 | 14 | $2K | |
| 99382 | 20 | 20 | $2K | |
| 86357 | 78 | 77 | $2K | |
| 73564 | 484 | 473 | $2K | |
| T1023 | Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter | 41 | 41 | $2K |
| 87486 | 69 | 68 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 16 | 16 | $2K |
| 87640 | 695 | 692 | $2K | |
| V2632 | Posterior chamber intraocular lens | 13 | 12 | $2K |
| 87077 | 1,217 | 1,174 | $2K | |
| 82670 | 69 | 61 | $2K | |
| 92202 | 25 | 25 | $2K | |
| 82043 | 428 | 426 | $2K | |
| 85046 | 1,468 | 1,324 | $2K | |
| H0001 | Alcohol and/or drug assessment | 13 | 13 | $2K |
| 82105 | 267 | 261 | $2K | |
| 86140 | 945 | 906 | $2K | |
| 84480 | 212 | 206 | $2K | |
| 90710 | 219 | 218 | $2K | |
| 82550 | 1,180 | 1,089 | $2K | |
| 84146 | 70 | 70 | $2K | |
| 82677 | 91 | 86 | $2K | |
| 86618 | 36 | 36 | $2K | |
| 82950 | 427 | 427 | $2K | |
| 87070 | 857 | 797 | $2K | |
| 74019 | 64 | 63 | $2K | |
| 84436 | 278 | 274 | $2K | |
| 73060 | 399 | 383 | $2K | |
| 76821 | 27 | 12 | $2K | |
| 84703 | 8,391 | 8,031 | $2K | |
| 99383 | 12 | 12 | $1K | |
| 76512 | 60 | 53 | $1K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 186 | 177 | $1K |
| 86695 | 49 | 48 | $1K | |
| 90656 | 80 | 80 | $1K | |
| 76885 | 13 | 13 | $1K | |
| 83516 | 29 | 28 | $1K | |
| 84144 | 58 | 51 | $1K | |
| D0340 | 24 | 24 | $1K | |
| Q2039 | Influenza virus vaccine, not otherwise specified | 56 | 56 | $1K |
| 87581 | 69 | 68 | $1K | |
| 86735 | 109 | 109 | $1K | |
| 83001 | 75 | 75 | $1K | |
| 84100 | 1,257 | 1,044 | $1K | |
| 92582 | 15 | 15 | $1K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 489 | 357 | $1K |
| 86704 | 85 | 84 | $1K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 388 | 284 | $1K |
| 87081 | 271 | 270 | $1K | |
| 86038 | 132 | 131 | $1K | |
| 82785 | 64 | 64 | $1K | |
| 81243 | 75 | 75 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 29 | 29 | $982.60 |
| 84704 | 97 | 92 | $963.98 | |
| 85651 | 314 | 308 | $956.67 | |
| 51702 | 12 | 12 | $945.74 | |
| 82330 | 2,866 | 2,703 | $936.74 | |
| 80365 | 447 | 370 | $907.25 | |
| 83002 | 46 | 46 | $892.35 | |
| 84481 | 72 | 72 | $881.18 | |
| D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | 295 | 248 | $865.00 |
| 87040 | 1,410 | 1,328 | $847.02 | |
| 82248 | 355 | 298 | $842.96 | |
| 96161 | 21 | 20 | $839.72 | |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 12 | 12 | $831.16 |
| 90749 | 52 | 52 | $819.58 | |
| 80164 | 84 | 74 | $799.75 | |
| 74220 | 12 | 12 | $793.09 | |
| 90744 | 62 | 61 | $790.80 | |
| 86696 | 48 | 48 | $783.49 | |
| 92225 | 12 | 12 | $779.77 | |
| 85379 | 2,035 | 1,999 | $779.46 | |
| 88311 | 12 | 12 | $776.00 | |
| 85652 | 947 | 914 | $761.20 | |
| 86160 | 30 | 30 | $757.91 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 27 | 27 | $755.04 |
| 73552 | 147 | 142 | $737.09 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 424 | 184 | $729.56 |
| 82465 | 183 | 183 | $723.46 | |
| 86336 | 97 | 83 | $699.88 | |
| Q3014 | Telehealth originating site facility fee | 63 | 59 | $689.18 |
| J1644 | Injection, heparin sodium, per 1000 units | 271 | 164 | $673.50 |
| 96133 | 147 | 121 | $672.61 | |
| 96136 | 15 | 13 | $671.49 | |
| D0210 | Intraoral - complete series of radiographic images | 42 | 40 | $671.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 441 | 438 | $668.13 |
| 84402 | 37 | 31 | $650.69 | |
| 86880 | 25 | 25 | $590.85 | |
| 82784 | 66 | 63 | $574.98 | |
| 84132 | 3,795 | 3,598 | $574.16 | |
| 86481 | 13 | 13 | $573.48 | |
| 80361 | 26 | 25 | $566.39 | |
| 82570 | 171 | 166 | $525.64 | |
| J2060 | Injection, lorazepam, 2 mg | 292 | 265 | $464.88 |
| 90696 | 72 | 72 | $464.26 | |
| 86430 | 76 | 75 | $453.35 | |
| 84466 | 43 | 43 | $439.56 | |
| 86376 | 24 | 24 | $436.77 | |
| 82977 | 72 | 70 | $433.55 | |
| 84550 | 199 | 190 | $431.16 | |
| 80324 | 13 | 12 | $428.36 | |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | 18 | 12 | $399.11 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 173 | 173 | $387.81 |
| D9990 | 73 | 68 | $374.00 | |
| 85245 | 12 | 12 | $373.81 | |
| 80346 | 13 | 12 | $359.75 | |
| 96137 | 16 | 13 | $356.82 | |
| 80353 | 42 | 37 | $326.18 | |
| 84156 | 131 | 122 | $315.86 | |
| 76000 | 13 | 13 | $304.70 | |
| 85045 | 190 | 162 | $304.12 | |
| 80358 | 13 | 12 | $291.13 | |
| 80345 | 13 | 12 | $291.13 | |
| 86592 | 72 | 71 | $283.07 | |
| 84300 | 559 | 524 | $266.08 | |
| 86225 | 25 | 25 | $263.72 | |
| 82652 | 14 | 14 | $262.99 | |
| 80329 | 317 | 309 | $250.33 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 83 | 75 | $247.35 |
| 82247 | 154 | 121 | $246.40 | |
| 86255 | 28 | 28 | $236.12 | |
| 86334 | 12 | 12 | $217.02 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 65 | 65 | $207.89 |
| 85246 | 12 | 12 | $205.92 | |
| 80349 | 65 | 61 | $205.05 | |
| 85007 | 499 | 486 | $203.37 | |
| J1630 | Injection, haloperidol, up to 5 mg | 186 | 163 | $189.70 |
| 99050 | 17 | 17 | $187.27 | |
| 80299 | 14 | 13 | $186.71 | |
| C9113 | Injection, pantoprazole sodium, per vial | 39 | 25 | $185.32 |
| 73620 | 25 | 25 | $175.36 | |
| 84295 | 2,998 | 2,842 | $173.27 | |
| 94200 | 12 | 12 | $156.00 | |
| 85384 | 58 | 50 | $118.85 | |
| J7070 | Infusion, d5w, 1000 cc | 75 | 49 | $118.05 |
| 80354 | 80 | 79 | $106.95 | |
| 73140 | 53 | 51 | $99.83 | |
| 82951 | 12 | 12 | $99.02 | |
| 82310 | 55 | 53 | $99.02 | |
| 90714 | 30 | 29 | $97.83 | |
| 86300 | 12 | 12 | $83.90 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 44 | 44 | $83.66 |
| 82010 | 399 | 383 | $73.48 | |
| 82947 | 25 | 25 | $72.88 | |
| 85018 | 3,653 | 3,471 | $72.05 | |
| 82150 | 16 | 14 | $69.59 | |
| 80178 | 13 | 12 | $68.61 | |
| 85014 | 2,939 | 2,787 | $66.00 | |
| 80348 | 185 | 162 | $65.00 | |
| 87205 | 92 | 89 | $63.33 | |
| 87088 | 19 | 18 | $62.78 | |
| 93041 | 566 | 545 | $59.28 | |
| 84479 | 54 | 51 | $57.69 | |
| 94761 | 50 | 49 | $51.15 | |
| 99152 | 68 | 67 | $49.57 | |
| 83921 | 13 | 13 | $47.26 | |
| 82948 | 276 | 175 | $40.12 | |
| 85044 | 24 | 24 | $39.15 | |
| 88302 | 26 | 26 | $39.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 13 | 13 | $37.27 |
| 82553 | 67 | 64 | $27.76 | |
| 84600 | 295 | 286 | $26.15 | |
| 83986 | 13 | 12 | $21.00 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 12 | 12 | $20.73 |
| 99173 | 26 | 26 | $14.84 | |
| J1836 | Injection, metronidazole, 10 mg | 14 | 12 | $13.47 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 15 | 15 | $8.62 |
| 84155 | 12 | 12 | $4.53 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 28 | 28 | $0.03 |
| 82657 | 56 | 56 | $0.00 | |
| D2331 | 32 | 31 | $0.00 | |
| D0170 | 21 | 19 | $0.00 | |
| D2330 | 12 | 12 | $0.00 | |
| 99080 | 560 | 161 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 28 | 28 | $0.00 |
| D2140 | 49 | 39 | $0.00 | |
| D8660 | 12 | 12 | $0.00 |